Approvals/TGA/PRICELINE PHARMACY MOMETASONE ALLERGY RELIEF mometasone furoate (as monohydrate) 50 mcg/ actuation suspension nasal spray bottle

Approved

STANDARD

PRICELINE PHARMACY MOMETASONE ALLERGY RELIEF mometasone furoate (as monohydrate) 50 mcg/ actuation suspension nasal spray bottle

Neo Health (OTC) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 12f8505da877e34e
Product Name: PRICELINE PHARMACY MOMETASONE ALLERGY RELIEF mometasone furoate (as monohydrate) 50 mcg/ actuation suspension nasal spray bottle
Artg Id: 285064
Artg Name: PRICELINE PHARMACY MOMETASONE ALLERGY RELIEF mometasone furoate (as monohydrate) 50 mcg/ actuation suspension nasal spray bottle
Sponsor: Neo Health (OTC) Pty Ltd
Company Detail Path: /organization/neo-health-otc-pty-ltd
Artg Date: 2017-01-30
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

12f8505da877e34e

Type

Standard